Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 48

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury

Haroon, Khan, Zheng, Haoran, Wu, Shengju, Liu, Ze, Tang, Yaohui, Yang, Guo-Yuan, Liu, Yingli, Zhang, Zhijun·2024·International Journal of Pharmaceutics

Abstract

Neuroprotection is one of the core treatment strategies for brain injuries including traumatic brain injury (TBI). NR2B9c is a promising neuroprotective peptide but its clinical translation is limited because of poor brain penetrability. Exosomes are naturally occurring nanovesicles having therapeutic potential for TBI as well as an efficient drug delivery carrier to the brain. Here, we engineered exosomes with neuron targeting peptide rabies virus glycoprotein (RVG29) via bio-orthogonal click chemistry technique and loaded it with NR2B9c, developing RVG-Exo NR2B9c . RVG29 conjugated exosome had higher neuron targeting efficiency compared to naïve exosomes both in vivo and in vitro. RVG-Exo NR2B9c had great cytoprotective effect against oxygen glucose deprived Neuro2a cells. Intravenous administration of RVG-Exo NR2B9c significantly improved behavioral outcomes and reduced the lesion volume after TBI injury in a mice controlled cortical impact model. Due to their multifunctionality and significant efficacy, we anticipate that RVG-Exo NR2B9c have the potential to be translated both as therapeutic agent as well as cargo delivery system to the brain for the treatment of TBI.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2023.123656

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

See all 48

Metadata

Authors
Haroon, K., Zheng, H., Wu, S., Liu, Z., Tang, Y., Yang, G.-Y., Liu, Y., & Zhang, Z.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2024-01
Volume
649
Pages
123656
ISSN
0378-5173
Cited by
48
References
49
Language
en
Funders
  • National Natural Science Foundation of China (82271320, 82371307, 81974179, 82071284, 8217030178)
  • Shanghai Rising-Star Program (21QA1405200)
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • National Key Research and Development Program of China (2019YFA0112000, 2022YFA1603604)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury. https://app.cochat.ai/papers/10.1016/j.ijpharm.2023.123656
The paper
Haroon, K., Zheng, H., Wu, S., Liu, Z., Tang, Y., Yang, G.-Y., Liu, Y., & Zhang, Z. (2024). Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2023.123656

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.